Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year As the biopharma and med-tech industries continue to evolve, 2024 proved to be a landmark year. The ...
LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the ...
Special series investigates what the new uses and alternatives are and what the future of radiopharmaceutical therapy might look like The radiopharmaceutical market is projected to be worth nearly $12 ...
Reviva Pharmaceuticals Holdings Inc. may be headed back to the clinic for another phase III study of brilaroxazine in treating schizophrenia. The U.S. FDA recommended the second study for the ...
The editors at BioWorld have released Biotechnology State of the Industry Report 2006, an analysis of 2005's year in biotech. The report contains 427 pages of proprietary market research that reveals ...
LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback